FDA inspection

Ascent Pharmaceuticals, Inc.: FDA inspection ending Jun 28, 2016

FDA inspection 976700 · No Action Indicated (NAI) · Central Islip, NY

Key facts

Inspection ID 976700
Firm Ascent Pharmaceuticals, Inc.
FEI number 3009518416
Address 400 S Technology Dr
City Central Islip
State NY
ZIP 11722-4402
Fiscal year 2016
Inspection end date Jun 28, 2016
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections